Asia Pacific Next Generation Sequencing (NGS) Market Trends and Segments Forecast To 2028
Author : vidhayani vidhayani | Published On : 16 Mar 2023
The asia pacific next generation sequencing (ngs) market size was valued at USD 570 million in 2021 and is expected to grow at a CAGR of 24.0% during the forecast period 2022-2028. Massively parallel sequencing (MPS) and next-generation sequencing (NGS) are words that describe a DNA sequencing technique that has greatly benefited biotechnology, medical diagnostics, forensic biology, biological systematics, and virology. The introduction of next-generation sequencing (NGS) has altered the way clinical research, fundamental science, and applied science are conducted. In comparison to prior Sanger sequencing technology, next-generation sequencing technology enables for the sequencing of a full human genome in a fraction of the time. The discovery of biomarkers for early diagnosis and individualized therapies is possible because to next-generation sequencing, which has influenced the shift from a traditional medicine paradigm of diagnosis to a precision medicine one. While Next Generation Sequencing is still relatively new, it has quickly established itself as a cornerstone of molecular biology and genetics, with applications in personalized medicine, hereditary disorders, and clinical diagnostics.
The cost of next-generation sequencing technology has dropped dramatically since the Human Genome Project was completed, and it is continuing to fall. Next-generation sequencing is becoming more inexpensive and accessible as costs continue to fall, resulting in market expansion. With the advent of next-generation sequencing has come an increase in the quantity and diversity of library preparation methods, and as capacities improve, sample preparation boundaries are being pushed as well. While this might make decision-making more difficult, it is expected that the availability of trained workers for sample preparation will rise, propelling the next-generation sequencing industry ahead. Furthermore, advances in sequencing technology are paving the way for possible breakthroughs in cancer, Mendelian illnesses, and other diseases. The difficulties in building in-house throughput devices, as well as the interpretation of complicated data from NGS platforms, are expected to stymie market expansion throughout the forecast period.
The asia pacific next generation sequencing (ngs) market segmentation:
1) By Type Products: Instruments & Software, Consumables (Reagents & kits) and Services (Sequencing Services and Data Analysis Services.
2) By Technology: Whole Targeted Re-sequencing, Whole Genome Sequencing, Transcriptome (RNA-Seq), Whole Exome Sequencing, De Novo Sequencing, ChiP Sequencing, Methylation Sequencing, and Others.
3) By Application: Diagnostics, Drug Discovery & Development, Biomarker Discovery, Agriculture & Animal Health Research, and Personalised Medicine.
4) By End User: Academic Institutes & Research Centers, Hospital/Clinical Laboratories, Biotech/Pharmaceuticals Companies, and Others.
The Asia Pacific Next-Generation Sequencing (NGS) Services Market is predicted to expand rapidly, as the area offers a significant potential for Next-Generation Sequencing (NGS) Services Marketers. Emerging economies like as China, India, and Japan are projected to fuel the Asia market, with a growth in the usage of NGS equipment, particularly for research reasons.
There are some major players working in asia-pacific next generation sequencing market, which include Agilent Technologies Inc., BGI (Beijing Genomics Institute), Biomatters Ltd., DNASTAR Inc., GATC Biotech Ag, Genomatix Software GmbH, Illumina Incorporated, Knome Inc., Life Sciences (Roche), Macrogen Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences, Partek Inc., Perkin Elmer Inc., Qiagen N.V, Thermo Fischer Scientific.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Precision Business Insights | Toll Free: +1 866 598 1553